| Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles AC Silva, A Kumar, W Wild, D Ferreira, D Santos, B Forbes International journal of pharmaceutics 436 (1-2), 798-805, 2012 | 141 | 2012 |
| The delivered dose: Applying particokinetics to in vitro investigations of nanoparticle internalization by macrophages RA Khanbeigi, A Kumar, F Sadouki, C Lorenz, B Forbes, LA Dailey, ... Journal of controlled release 162 (2), 259-266, 2012 | 82 | 2012 |
| A Biocompatible Synthetic Lung Fluid Based on Human Respiratory Tract Lining Fluid Composition A Kumar, W Terakosolphan, M Hassoun, KK Vandera, A Novicky, ... Pharmaceutical research 34 (12), 2454-2465, 2017 | 68 | 2017 |
| Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid A Kumar, EM Bicer, AB Morgan, PE Pfeffer, M Monopoli, KA Dawson, ... Nanomedicine: Nanotechnology, Biology and Medicine 12 (4), 1033-1043, 2016 | 68 | 2016 |
| Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery F Martinelli, AG Balducci, A Kumar, F Sonvico, B Forbes, R Bettini, ... International journal of pharmaceutics 517 (1-2), 286-295, 2017 | 49 | 2017 |
| Use of PBPK modelling to evaluate the performance of DissolvIt, a biorelevant dissolution assay for orally inhaled drug products M Hassoun, M Malmlof, O Scheibelhofer, A Kumar, S Bansal, E Selg, ... Molecular Pharmaceutics, 2019 | 28 | 2019 |
| Quantifying the magnitude of the oxygen artefact inherent in culturing airway cells under atmospheric oxygen versus physiological levels A Kumar, LA Dailey, M Swedrowska, R Siow, GE Mann, ... FEBS letters 590 (2), 258-269, 2016 | 27 | 2016 |
| Morphometric Characterization of Rat and Human Alveolar Macrophage Cell Models and their Response to Amiodarone using High Content Image Analysis E Hoffman, A Patel, D Ball, J Klapwijk, V Millar, A Kumar, A Martin, ... Pharmaceutical research 34 (12), 2466-2476, 2017 | 21 | 2017 |
| Lost in translation: what is stopping inhaled nanomedicines from realizing their potential? A Kumar, LA Dailey, B Forbes Therapeutic delivery 5 (7), 757-761, 2014 | 19 | 2014 |
| In Vitro Multiparameter Assay Development Strategy toward Differentiating Macrophage Responses to Inhaled Medicines E Hoffman, A Kumar, V Kanabar, M Arno, L Preux, V Millar, C Page, ... Molecular pharmaceutics 12 (8), 2675-2687, 2015 | 18 | 2015 |
| In Silico and in Vitro Screening for P-Glycoprotein Interaction with Tenofovir, Darunavir, and Dapivirine: An Antiretroviral Drug Combination for Topical Prevention … M Swedrowska, S Jamshidi, A Kumar, C Kelly, KM Rahman, B Forbes Molecular pharmaceutics 14 (8), 2660-2669, 2017 | 17 | 2017 |
| Differences in the coronal proteome acquired by particles depositing in the lungs of asthmatic versus healthy humans A Kumar, EM Bicer, P Pfeffer, MP Monopoli, KA Dawson, J Eriksson, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (8), 2517-2521, 2017 | 16 | 2017 |
| What are the biological and therapeutic implications of biomolecule corona formation on the surface of inhaled nanomedicines? A Kumar, B Forbes, I Mudway, EM Bicer, LA Dailey Nanomedicine 10 (3), 343-345, 2015 | 13 | 2015 |
| Solubility of fluticasone propionate and beclomethasone dipropionate in simulated lung lining fluids W Terakosolphan, M Hassoun, A Kumar, B Forbes JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 30 (4), A27-A27, 2017 | 3 | 2017 |
| Inhaled nanoparticles develop a complex protein corona: biological importance and implications for sustained release formulations A Kumar, M Bicer, P Pfeffer, M Monopoli, K Dawson, A Blomberg, ... Drug Delivery to the Lungs–DDL25. Edinburgh, UK, 10-12, 2014 | 3* | 2014 |
| In vivo safety and particokinetics of inhaled nanomedicines MC Jones, A Kumar, D Spina, B Forbes, C Page, LA Dailey Journal of Drug Delivery Science and Technology 21 (4), 339-346, 2011 | 3 | 2011 |
| Inhaled nanoparticles develop a complex protein corona of biological importance A Kumar, EM Bicer, P Pfeffer, M Monopoli, K Dawson, A Blomberg, ... J Aerosol Med Pulm Drug Deliv 28, A3-A4, 2015 | 1 | 2015 |
| Current strategies for anti-retroviral drug transport across vaginal and rectal epithelium C Kelly, C Carserides, M Zinicola, M Swedrowska, S Monk, A Kumar, ... It's just mucosa, get over it..., 29, 2014 | 1 | 2014 |
| Characterisation of Interspecies Differences between Human and Rat Airway Macrophage Responses in vitro E Hoffman, A Kumar, R Mahendran, A Patel, V Millar, M Clements, ... JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 30 (4), A12-A12, 2017 | | 2017 |
| EFFECT OF USING BIO-RELEVANT MEDIA IN THE DISSOLVIT (R) SYSTEM TO MEASURE DISSOLUTION OF FLUTICASONE FROM FLIXOTIDE 50 mu G EVOHALER M Hassoun, M Malmlof, A Kumar, S Bansal, P Gerde, B Forbes JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 30 (4), A26-A27, 2017 | | 2017 |
